Current vs Average Quick Ratio
How the latest reported quick ratio of 1.81 compares to its TTM/3Y/5Y/10Y/15Y/20Y averages as of Tuesday, March 31, 2026.
PODD Current vs Average Quick Ratio
PODD Quick Ratio vs Average
CURRENT VS TTM AVG
-21.04%
CURRENT VS 3Y AVG
-23.41%
CURRENT VS 5Y AVG
-41.22%
CURRENT VS 10Y AVG
-54.29%
CURRENT VS 15Y AVG
-54.19%
CURRENT VS 20Y AVG
-55.57%
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy